Literature DB >> 21725925

Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients.

Antonio Bellasi1, Emiliana Ferramosca, Carlo Ratti, Geoffrey Block, Paolo Raggi.   

Abstract

BACKGROUND: Vascular and valvular calcifications are a common finding in chronic kidney disease (CKD) patients and are associated with increased morbidity and mortality. We investigated the hypothesis that calcification of the cardiac valves is a marker of coronary artery calcification (CAC) and thoracic aorta calcification (AoC) in hemodialysis (CKD-5) patients.
METHODS: This was a cross-sectional study of 145 maintenance CKD stage 5 (CKD-5) patients. All patients underwent electron beam tomography for quantification of CAC and AoC score via the Agatston score. The presence of calcification of the cardiac valves was assessed by standard bi-dimensional echocardiography.
RESULTS: Eighty-four of the study patients (58%) had echocardiographic evidence of valvular calcification. A significant and graded association between valvular calcification and CAC as well as AoC was detected. Patients with 1 or 2 calcified valves had a significantly greater likelihood of having a CAC score >1,000 (odds ratio [OR] = 5.94; 95% confidence interval [95% CI], 1.91-18.44; p=0.002; and OR=3.27; 95%CI, 1.36-7.88; p=0.007, respectively). Similarly, the presence of 1 or 2 calcified valves was associated with an eightfold and threefold increased probability of an AoC score greater than the third quartile, respectively.
CONCLUSIONS: This cross-sectional analysis shows that calcification of the cardiac valves is closely associated with vascular calcification, an established marker of risk in prevalent hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21725925     DOI: 10.5301/JN.2011.8446

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  10 in total

1.  Relationship between cardiac calcification and left ventricular hypertrophy in patients with chronic kidney disease at hemodialysis initiation.

Authors:  Ken Kitamura; Hideki Fujii; Kentaro Nakai; Keiji Kono; Shunsuke Goto; Tatsuya Nishii; Atsushi Kono; Shinichi Nishi
Journal:  Heart Vessels       Date:  2017-03-21       Impact factor: 2.037

Review 2.  Reducing cardiovascular mortality in chronic kidney disease: something borrowed, something new.

Authors:  L Darryl Quarles
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

3.  Risk Factors for New-Onset Cardiac Valve Calcification in Patients on Maintenance Peritoneal Dialysis.

Authors:  Yunhuan Tian; Sheng Feng; Zhoubing Zhan; Ying Lu; Yancai Wang; Shan Jiang; Kai Song; Huaying Shen
Journal:  Cardiorenal Med       Date:  2016-02-04       Impact factor: 2.041

4.  Is residual renal function and better phosphate control in peritoneal dialysis an answer for the lower prevalence of valve calcification compared to hemodialysis patients?

Authors:  Merita Rroji; Saimir Seferi; Majlinda Cafka; Elizana Petrela; Erjola Likaj; Myftar Barbullushi; Nestor Thereska; Goce Spasovski
Journal:  Int Urol Nephrol       Date:  2013-04-17       Impact factor: 2.370

5.  Differences between diabetic and non-diabetic nephropathy patients in cardiac structure and function at the beginning of hemodialysis and their impact on the prediction of mortality.

Authors:  Chao Tang; Han Ouyang; Jian Huang; Jing Zhu; Xiaosong Gu
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

6.  Prevalence and Correlates of Cardiovascular Calcification and Its Prognostic Effects Among Patients With Chronic Kidney Disease: Results From the C-STRIDE Study.

Authors:  Lan Wang; Hong Cheng; Xinrong Zou; Jun Yuan; Wenjing Wu; Siping Han; Jinwei Wang; Luxia Zhang; Kevin He; Ming-Hui Zhao; Xiaoqin Wang
Journal:  Front Public Health       Date:  2022-01-06

7.  Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism.

Authors:  Kazunori Nakayama; Kazushi Nakao; Yuji Takatori; Junko Inoue; Shoichirou Kojo; Shigeru Akagi; Masaki Fukushima; Jun Wada; Hirofumi Makino
Journal:  Int J Nephrol Renovasc Dis       Date:  2013-12-18

8.  Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era.

Authors:  Giovanni Conzo; Alessandra F Perna; Vincenzo Savica; Antonietta Palazzo; Cristina Della Pietra; Diego Ingrosso; Ersilia Satta; Giovambattista Capasso; Luigi Santini; Giovanni Docimo
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

Review 9.  Hyperphosphatemia Management in Patients with Chronic Kidney Disease.

Authors:  Ahmed M Shaman; Stefan R Kowalski
Journal:  Saudi Pharm J       Date:  2015-01-12       Impact factor: 4.330

Review 10.  Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis.

Authors:  Zhe Wang; Aili Jiang; Fang Wei; Haiyan Chen
Journal:  BMC Cardiovasc Disord       Date:  2018-01-25       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.